Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. [PDF]
Ziółkowska EA +5 more
europepmc +1 more source
Elevated tripeptidyl-peptidase 1 corrects multiple disease phenotypes in a mouse model of juvenile neuronal ceroid lipofuscinosis. [PDF]
Banach-Petrosky W +10 more
europepmc +1 more source
The yeast phosphofructokinase β-subunit has RNA unwinding activity and modulates cell cycle progression. [PDF]
Albihlal WS +10 more
europepmc +1 more source
Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease. [PDF]
Ziółkowska EA +8 more
europepmc +1 more source
Impact of CLN3 Disease on Child Quality of Life and Family Function. [PDF]
Vermilion J +6 more
europepmc +1 more source
Discovery of Functionalized 1<i>H</i>-Benzo[<i>d</i>]imidazoles That Confer Protective Effects in a Phenotypic CLN3 Disease Patient-Derived iPSC Model. [PDF]
Simeon P +6 more
europepmc +1 more source
Correction: CLN3 disease disrupts very early postnatal hippocampal maturation. [PDF]
Singh JB +8 more
europepmc +1 more source
Genetic pleiotropy underlying obesity and autoimmune disorders: a large-scale cross-trait gwas analysis in European ancestry populations. [PDF]
Jiang X +5 more
europepmc +1 more source
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom. [PDF]
Mole SE +14 more
europepmc +1 more source
Gut-Brain Interactions in Neuronal Ceroid Lipofuscinoses: A Systematic Review Beyond the Brain in Paediatric Dementias. [PDF]
Della Vecchia S +3 more
europepmc +1 more source

